Citation Impact
Citing Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
2000 Standout
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
Molecular Cloning and Characterization of an Aquaporin cDNA from Salivary, Lacrimal, and Respiratory Tissues
1995 StandoutNobel
The Third Intergroup Rhabdomyosarcoma Study.
1995 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
1991
Cisplatin and radiotherapy in the management of locally advanced head and neck cancer
1993
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
1989
Swallowing Disorders in Head and Neck Cancer Patients Treated With Radiotherapy and Adjuvant Chemotherapy
1996
Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas
1990
Chemotherapy for malignant gliomas
1988
Cisplatin resistance in human cancers
1991
Cardiac Failure and Dysrhythmias 6–19 Years After Anthracycline Therapy: A Series of 15 Patients
1995
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
High-dose methotrexate: a critical reappraisal.
1987
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
1998
Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the southwest oncology group
1988
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer
2001
Clinical applications of quinone-containing alkylating agents
2000
Treatment of head and neck cancer: the role of chemotherapy
1996
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: Preliminary report of a randomized trial
1991
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Toxicity in head and neck cancer: a review of trends and issues
2000
Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study.
1989
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal
1995
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials
1993
Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study
1997
Management of head and neck cancer
1994
Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer
1990
The pathobiology of mucositis
2004 Standout
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
2004
Adjuvant chemotherapy in head and neck cancer
1990
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
1995
Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.
1990
TNF-α targeted therapeutic approaches in patients with hematologic malignancies
2002
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Head and Neck Cancer
1993 Standout
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.
1992 Standout
Concomitant chemoradiotherapy with cisplatin, 5‐fluorouracil and hydroxyurea in poor‐prognosis head and neck cancer
1992
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
2004
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial
2002
Delaying surgery with chemotherapy for osteosarcoma of the extremities
2004
Simultaneous Radiotherapy and Chemotherapy with Carboplatin in Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase II Study
1992
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
1991
Altered fractionation in the treatment of head and neck cancer
1999
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: A southwest oncology group trial
1990
Toxicity antagonists in head and neck cancer
1998
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
1991 Standout
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.
1992
Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation
1992
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
1997
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.
1993
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.
1996
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
2000
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck
1992
Head and Neck Cancer
2001 Standout
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck
1994
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
2011
Nursing Management of Adriamycin Extravasation
1979
Adriamycin
1974 Standout
Echocardiographic assessment of anthracycline cardiotoxicity in children
1978
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Adriamycin Cardiotoxicity in Man
1974
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Induction Chemotherapy for Head and Neck Cancer: Will History Repeat Itself?
2005
Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
2004
The cardiotoxicity of adriamycin and daunomycin in children
1976
Echocardiography in adriamycin cardiotoxicity
1978
The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma
1975
Adriamycin: A new effective agent in the therapy of disseminated sarcomas
1975
The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity
1986 Standout
Topical Instillation of Doxorubicin Hydrochloride in the Treatment of Recurring Superficial Transitional Cell Carcinoma of the Bladder
1977
Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy
1979
Radiotherapy with Concomitant Chemotherapy for Head and Neck Cancer
1991
Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy
1990
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
1979 Standout
Randomized Trials of Induction Chemotherapy: A Critical Review
1991
Adjuvant chemotherapy in head and neck cancer
1992
Randomized clinical trial of mitomycin c as an adjunct to radiotherapy in head and neck cancer
1989
Doxorubicin Cardiotoxicity: Assessment of Late Left Ventricular Dysfunction By Radionuclide Cineangiography
1981
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
1987
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.
1974
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
1987
Clinico-pathologic correlation of liver damage in patients treated with 6-mercaptopurine and adriamycin
1976
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
1980 StandoutNobel
Adjuvant Chemotherapy in Head and Neck Cancer.
1992
Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the northern California oncology group
1987
The Anthracycline Antineoplastic Drugs
1981 Standout
Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
1991 Standout
Up-Front Window Trial of Topotecan in Previously Untreated Children and Adolescents With Metastatic Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study
2001
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
2001 Standout
Chemotherapy of advanced soft-tissue sarcomas in adults
1977
Works of John Showel being referenced
Concomitant chemotherapy and split‐course radiation for cure and preservation of speech and swallowing in head and neck cancer
1991
Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes
1996
Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer.
1989
Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy
1987
Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.
1994
A randomized trial of adjuvant chemotherapy in head and neck cancer.
1985
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A phase ii study by the illinois cancer council
1985
Adriamycin—an antitumor antibiotic in the treatment of neoplastic diseases
1973
Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy.
1985
A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
1984
Surgical Complications in Patients With Head and Neck Cancer Receiving Chemotherapy
1986
Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
1986